Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

Lecia V. Sequist, Martin Schüler, Wu‐Chou Su et al.|Journal of Clinical Oncology|2013

Cited by 3.2k